The fatal attraction of polyglutamine-containing proteins

Clinical Genetics

Volumn 53, Issue 4, 1998, Pages 233-242

  Hackam, Abigail S ^a   Wellington, Cheryl L ^a   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE;

BRAIN CORTEX; CELL DEATH; DEGENERATIVE DISEASE; GENE MUTATION; HUMAN; NERVE CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; REVIEW;

EID: 0031970977     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb02687.x     Document Type: Review

References (36)

1. David G, Abbas N, Stevanin G, Durr A, Yvert G, Cancel G, Weber C, Imbert G, Saudou F, Antoniou E, Drabkin H, Gemmill R, Giunti P, Benomar A, Wood N, Ruberg M, Agid Y, Mandel JL, Brice A. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 1997: 17: 65-70.
2. Koshy BT, Zoghbi HY. The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis. Brain Pathol 1997: 7: 927-942.
3. Martindale D, Hackam AS, Wieczorek A, Ellerby L, Wellington CL, McCutcheon K, Singaraja R, Kazemi-Esfarjani P, Devon R, Bredesen DE, Tufaro F, Hayden MR. Length of the protein and polyglutamine tract influence localization and frequency of intracellular aggregates of huntingtin. Nat Genet 1988: 18: 150-154.
4. Nance MA. Clinical aspects of CAG repeat diseases. Brain Pathol 1997: 7: 881-900.
5. Robitaille Y, Lopes-Cendes I, Becher M, Rouleau GA, Clark AW. The neuropathology of CAG repeat diseases: review and update of genetic and molecular features. Brain Pathol 1997: 7: 901-926.
6. Ross CA, Becher MW, Colomer V, Engelender S, Wood JD, Sharp AH. Huntington's disease and dentatorubral-pallidoluysian atrophy: proteins, pathogenesis and pathology. Brain Pathol 1997: 7: 1003-1016.
7. Wellington CL, Brinkman RR, O'Kusky JR, Hayden MR. Toward understanding the molecular pathology of Huntington's disease. Brain Pathol 1997: 7: 979-1002.
8. Andrew SE, Goldberg YP, Hayden MR. Commentary: rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet 1997: 6: 2005-2010.
9. Ross CA. When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 1995: 15: 493-496.
10. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997: 90: 537-548.
11. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neuroties in brain. Science 1997: 277: 1990-1993.
12. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wanker EE. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 1997: 90: 549-558.
13. Hackam, AS, Singaraja, R, Wellington, CL, Metzler, M, McCutcheon, K, Zhang, E, Kalchman, M, Hayden, MR. Increasing toxicity and aggregates with truncated huntingtin support the toxic fragment hypothesis for the pathogenesis of Huntington disease (submitted).
14. Skinner PJ, Koshy BT, Cummings CJ, Klement IA, Helin K, Servadio A, Zoghbi HY. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 1997: 389: 971-974.
15. Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel J-L, Fischbeck KH, Pittman RN. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997: 19: 333-334.
16. Ellerby, LM, Hackam, AS, Propp, SS, Ellerby, HM, Rabizadeh, S, Trifiro, MA, Pinsky, L, Wellington, CL, Salvesen, GS, Hayden, MR, Bredesen, DE. Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity (submitted).
17. Becher, MW, Kotzuk, JA, Sharp, AH, Davies, SW, Bates, GP, Price, DL, Ross, CA. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis 1997 (in press).
18. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996: 87: 493-506.
19. Ordway JM, Tallaksen-Greene S, Gutekunst C-A, Bernstein EM, Cearley JA, Wiener HW, Dure L, Lindsey R, Hersch SM, Jope RS, Albin RL, Detloff PJ. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 1997: 91: 753-763.
20. Igarashi S, Koide R, Shimohata T, Yamada M, Hayashi Y, Takano H, Date H, Oyake M, Sato T, Sato A, Egawa S, Ikeuchi T, Tanaka H, Nakano R, Tanaka K, Hozumi I, Inuzuka T, Takahashi H, Tsuji S. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet 1998: 18: 111-117.
21. Dingwall C, Laskey RA. Nuclear targeting sequences - a consensus? Trends Biochem Sci 1991: 16: 478-481.
22. Gorlich D, Mattaj IW. Nucleocytoplasmic transport. Science 1996: 271: 1513-1518.
23. Newmeyer DD, Lucocq JM, Burglin TR, De RE. Assembly in vitro of nuclei active in nuclear protein transport: ATP is required for nucleoplasmin accumulation. EMBO J 1986: 5: 501-510.
24. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Gromm M, Kazemi-Esfarjani P, Thornberry NA, Vaillancourt JP, Hayden MR. Clevage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet 1996: 13: 442-449.
25. Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R, McCutcheon K, Salvesen GS, Propp SS, Bromm M, Rowland KJ, Zhang T, Rasper D, Roy S, Thornberry N, Pinsky L, Kakizuka A, Ross CA, Nicholson DW, Bredesen, DE, Hayden MR. Caspase clevage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 1988 (in press).
26. Martin JB, Green DR. Protease activation during apoptosis: Death by a thousand cuts? Cell 1995: 82: 349-352.
27. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cell 1986: 44: 817-829.
28. Perutz MF. Glutamine repeats as polar zippers: their role in inherited neurodegenerative disease. Molecular Medicine 1995: 1: 718-721.
29. Perutz MF. Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. Curr Opin Struct Biol 1996: 6: 848-858.
30. Burright EN, Davidson JD, Duvick LA, Koshy B, Zoghbi HY, Orr HT. Identification of a self-associated region within the SCA1 gene product, ataxin-1. Hum Mol Genet 1997: 6: 513-518.
31. Folk JE. Transglutaminases. Annu Rev Biochem 1980: 49: 517-531.
32. Aeschlimann D, Paulsson M. Transglutaminases: protein cross-linking enzymes in tissues and body fluids. Thrombosis Haemostasis 1994: 71: 402-415.
33. Cooper AJ, Sheu K-F, Burke J, Onodera O, Strittmattter W, Roses A, Blass JP. Transglutaminase-catalyzed inactivation of glyceraldehyde-3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proc Natl Acad Sci USA 1997: 94: 12604-12609.
34. Matilla A, Koshy BT, Cummings CJ, Isobe T, Orr HT, Zoghbi HY. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 1997: 389: 974-978.
35. Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, Goldberg YP, Gietz RD, Pickart CM, Hayden MR. Huntingtin is ubiquitinated and interacts with a specific ubiquitin conjugated enzyme. J Biol Chem. 1996: 271: 19385-19394.
36. Brinkman RR, Mezei MM, Thielmann J, Almqvist E, Hayden MR. The liklihood of being affected with Huntington disease by a particular age for a specific CAG size. Am J Hum Genet 1997: 60: 1202-1210.